Clinical Trial Update: A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 1/2 study of CP-4055 in patients with refractory/relapsed hematologic malignancies, including acute myeloi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CP-4055

Snippet

Sponsor: Clavis Pharma | Conditions: Hematologic Malignancies, AML | Phase 1, Phase 2 | Status: COMPLETED